It was approved by the FDA of the United States as a medicine for ovary cancer and galactophore cancer.And it appeared on market in 1992.

• 1992年美国食品与药物管理局（FDA）批准紫杉醇用于治疗卵巢癌和乳腺癌的新药上市。